… and more specifically deep brain stimulation of the globus pallidus … are the ethical, practical
and safety issues concerning the … from platelets of parkinsonian patients, with proportional …

… to treat patients with movement disorders, such as Parkinson’s … This study was approved
by the local ethics committee of the … In regards to the safety of DBS, no severe adverse events …

… cells for modeling and cell therapy of Parkinson’s disease … hibitor carbidopa, and deep brain
stimulation to the nucleus subtha… However, there still remain safety concerns in the terms of …

… multidisciplinary intensive rehabilitation in patients with different Parkinson’s disease motor
… , and poorer response to dopaminergic treatment and deep brain stimulation (DBS) (Alves et …

… the 1980s when patients suffering from Parkinson’s disease (… of in-depth research evaluating
its therapeutic safety among … given the less related ethical and immunorejection problems[…

… with cerebral ischemia[33]. Several studies have reported that dopamine D2 receptor
stimulation may protect … in basal ganglia in dementia with Lewy bodies, Parkinson's disease and …

… protective ability as free non-Fe hemin. A positive effect on neuron survival in several in vivo
models of Parkinson’… clinical studies would raise possible ethical concerns. Obtaining neural …

… In conclusion, the ZrO 2 ceramic foam is promising for the development of a GDNF mass
production device for Parkinson’s disease treatment. … Compliance with ethics guidelines …

… in the subventricular zone in Parkinson’s disease model mice … clinical efficacy and safety of
EGb761 in vascular dementia[3-5, … Ethical approval: This study was approved by the Animal …

… neurodegenerative diseases, including Parkinson’s disease, … , risks of tumorigenicity, and
ethical concerns, most results of … relief through neurotrophic and protective effects. A recent …